Antibiotic prophylaxis in patients who had undergone to prostate biopsy in between the EMA warning era: effects of fluoroquinolones in diabetic and non-diabetic patients. Results of an observational cohort study - Top-Institutions - MDSpire

Antibiotic prophylaxis in patients who had undergone to prostate biopsy in between the EMA warning era: effects of fluoroquinolones in diabetic and non-diabetic patients. Results of an observational cohort study

  • By

  • Riccardo Bartoletti

  • Francesco Claps

  • Gabriele Tulone

  • Alessandro Perotti

  • Alessandro Zucchi

  • Niccolò Riccardi

  • Vincenzo Ficarra

  • Cosimo De Nunzio

  • Andrea Tubaro

  • Alchiede Simonato

  • June 10, 2022

  • 0 min

Share

Top Institutions in Urology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Urology
    • Infectious Diseases
    • Oncology

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Urology
    • Endocrinology
    • Infectious Diseases

  • #3

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Urology
    • Infectious Diseases
    • Clinical Pharmacology

  • #4

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Urology
    • Infectious Diseases
    • Diabetes Care

  • #5

    Karolinska Institutet
    Karolinska Institutet

    Stockholm, N/A

    Key Differentiators

    • Urology
    • Infectious Diseases
    • Clinical Epidemiology

Original Source(s)

Antibiotic prophylaxis in patients who had undergone to prostate biopsy in between the EMA warning era: effects of fluoroquinolones in diabetic and non-diabetic patients. Results of an observational cohort study

  • by Riccardo Bartoletti, Francesco Claps, Gabriele Tulone, Alessandro Perotti, Alessandro Zucchi, Niccolò Riccardi, Vincenzo Ficarra, Cosimo De Nunzio, Andrea Tubaro, Alchiede Simonato

  • June 10, 2022

Related Content

Vacuum-assisted mini-percutaneous nephrolithotomy is associated with lower rates of infectious complications compared to vacuum-cleaner procedure in patients at high risk for infections: a single-center experience

Risk of UTI in kidney stone formers: a matched-cohort study over a median follow-up of 19 years

International Kidney Cancer Collaboration with Leadership from Philadelphia

Kidney cancer is a growing global health problem, and both clinicians and policymakers need to prepare for a steep rise in the number of cases,” said Alexander Kutikov, MD, FACS, Chair of the Department of Urology at Fox Chase Cancer Center, and senior author of a landmark international study published in European Urology, which demonstrates that if current trends continue, kidney cancer cases could double by 2050

  • by

  • December 2, 2025

  • 3 min